Mersana Therapeutics
MRSN
MRSN
152 hedge funds and large institutions have $562M invested in Mersana Therapeutics in 2022 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 62 increasing their positions, 27 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
54% more capital invested
Capital invested by funds: $366M → $562M (+$196M)
21% more funds holding
Funds holding: 126 → 152 (+26)
0.15% more ownership
Funds ownership: 3.64% → 3.8% (+0.15%)
Holders
152
Holding in Top 10
4
Calls
$107K
Puts
$9K
Top Buyers
| 1 | +$16.5M | |
| 2 | +$6.3M | |
| 3 | +$5.59M | |
| 4 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
+$4.67M |
| 5 |
D.E. Shaw & Co
New York
|
+$4.37M |
Top Sellers
| 1 | -$14.6M | |
| 2 | -$12.1M | |
| 3 | -$4.05M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$2.64M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.4M |